NCT01230931 is a NA clinical trial of Vitagel in Fracture Fixation, sponsored by The University of Texas Health Science Center, Houston.

Who is sponsoring NCT01230931?

NCT01230931 is sponsored by The University of Texas Health Science Center, Houston.

What drugs are being tested in NCT01230931?

Interventions in NCT01230931: Vitagel, Standard of care.

What condition does NCT01230931 study?

NCT01230931 studies Fracture Fixation, Intra-Articular Fractures, Acetabulum.

Is NCT01230931 still recruiting?

NCT01230931 is currently terminated. Last updated 20 November 2018.

Are results published for NCT01230931?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2018-11-20 · How we verify

NCT01230931

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hemostasis in Kocher-Langenbeck Approaches for Acetabular Surgery Using a Topical Surgical Hemostat

Terminated NA Results posted Last updated 20 November 2018

What this trial tests

NA trial testing Vitagel in Fracture Fixation in 26 participants. Terminated before completion.

Timeline

1 October 2010

Primary endpoint
1 April 2012

1 April 2012

Quick facts

Lead sponsor	The University of Texas Health Science Center, Houston
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	26
Start date	1 October 2010
Primary completion	1 April 2012
Estimated completion	1 April 2012
Sites	1 location across United States

Drugs / interventions tested

Vitagel
Standard of care

Conditions studied

Fracture Fixation — all drugs for Fracture Fixation →
Intra-Articular Fractures — all drugs for Intra-Articular Fractures →
Acetabulum — all drugs for Acetabulum →

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Adults 18 to 65, any sex, with Fracture Fixation or Intra-Articular Fractures. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Intra-operative Rate of Blood Volume Loss
Time frame: at the time of surgery
The amount of blood loss during the surgery as measured by cell saver and lap counts. The cell saver and lap count totals will be summed.

Sponsor's own description

The purpose of the study is to determine whether surgical hemostats can minimize blood loss, need for allogeneic blood transfusions and their associated risks, and costs in patients with certain acetabular fractures requiring operative fixation via a non-extensile Kocher-Langenbeck surgical approach. Since surgical hemostats and other topical agents like platelet gel products have also been linked with improved wound healing, incidence of wound dehiscence and/or infections will also be examined. The investigators primary hypothesis is the topical hemostat will result in lower blood losses intraoperatively and fewer units of perioperative blood product transfused.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fracture Fixation

Currently open trials in the same condition.

NCT07234396 — Animated Video and Associated Pain and Anxiety Reduction, Following Pin Removal Post-supracondylar Fracture Fixation · NA · recruiting
NCT06806410 — The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery · Phase 4 · active not recruiting

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01230931 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
Last refreshed: 20 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01230931.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing